Riskpilot← Back to searchSign inGet full accessUNIBIO A/S
A/SActiveCVR 26110262Langebjerg 1Research and experimental development on natural sciences and engineering · NACE 7210Est. 200179 employeeswww.unibiogroup.com
Revenue 2024
DKK -717K
-153% vs 2023
EBITDA margin
14551.9%
-34% vs 2023
Equity ratio
72.4%
Financial strength
Net profit 2024
DKK -95,9M
-22% vs 2023
| Revenue | DKK -717K | -153% |
| EBITDA | DKK -104,3M | -34% |
| Net profit | DKK -95,9M | -22% |
| Total assets | DKK 81,9M | -53% |
| Equity | DKK 59,3M | -62% |
| Employees | 79 | — |
Legal name
UNIBIO A/S
CVR number
26110262
Legal form
Aktieselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
1. juli 2001
Share capital
DKK 14.750.000
Employees
79 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den administrerende direktør i forening med en anden direktør eller af formanden for bestyrelsen i forening med en direktør eller af formanden for bestyrelsen i forening med et andet bestyrelsesmedlem
Company purpose
Selskabets formål er forskning, udvikling, produktion, fabrikation, handel og andet i forbindelse hermed beslægtet virksomhed efter selskabets skøn.
Address
Langebjerg 1
Phone
+4563104040
Email
unibio@unibio.dk
Website
www.unibiogroup.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 59 | -1.577 | -3.588 | -2.688 | 1.141 | -2.313 | -7.449 | -10.422 | -13.099 | -13.393 | -12.558 | 1.344 | -717 |
| Staff expenses | -1.021 | -1.594 | -1.463 | -3.261 | -7.309 | -11.614 | -14.830 | -19.369 | -27.712 | -31.240 | -41.457 | -0 | -0 |
| EBITDA | -2.469 | -3.172 | -5.052 | -5.949 | -6.168 | -13.927 | -22.279 | -29.791 | -40.811 | -44.633 | -54.015 | -78.011 | -104.337 |
| Depreciation & amort. | -207 | -62 | -3.984 | -225 | -944 | -2.306 | -2.672 | -2.877 | -3.921 | -3.758 | -4.474 | -0 | -0 |
| EBIT | -2.676 | -3.234 | -9.036 | -6.174 | -7.112 | -16.233 | -24.951 | -32.668 | -44.732 | -48.391 | -58.489 | -78.011 | -104.337 |
| Net financials | -84 | -12 | 2 | 0 | 3 | -309 | -619 | -649 | -2.420 | 858 | 3.664 | 2.163 | 2.930 |
| Profit before tax | -2.760 | -3.246 | -9.033 | -6.174 | -7.109 | -16.542 | -25.570 | -33.317 | -47.152 | -47.533 | -54.825 | -76.548 | -101.407 |
| Tax | -566 | -808 | -1.796 | -1.543 | -1.557 | -3.636 | -5.617 | -7.332 | -5.409 | -5.684 | -5.500 | 1.788 | -5.500 |
| Net profit | -2.194 | -2.437 | -7.237 | -4.631 | -4.554 | -12.906 | -19.953 | -25.985 | -41.743 | -41.849 | -49.325 | -78.336 | -95.907 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 8.146 | 8.542 | 8.205 | 11.594 | 29.045 | 34.320 | 44.432 | 105.535 | 67.668 | 118.876 | 71.344 | 174.899 | 81.895 |
| Equity | 7.113 | 7.676 | 4.844 | 7.213 | 14.661 | 15.755 | 15.801 | 66.447 | 24.705 | -17.144 | 33.531 | 155.195 | 59.288 |
| Long-term debt | 0 | 0 | 1.304 | 1.376 | 1.659 | 6.840 | 6.863 | 7.030 | 7.585 | 0 | 0 | 0 | 0 |
| Short-term debt | 1.033 | 867 | 3.362 | 4.381 | 14.384 | 11.725 | 21.768 | 32.058 | 35.378 | 136.020 | 37.813 | 19.704 | 22.607 |
| Total debt | 1.033 | 867 | 3.362 | 4.381 | 14.384 | 18.565 | 28.631 | 39.088 | 42.963 | 136.020 | 37.813 | 19.704 | 22.607 |
EBITDA margin
-10433700000.0%
This company
15.8%
Market median
-66036076049% vs market
20122024
Equity ratio
72.4%
This company
38.2%
Market median
+90% vs market
20122024
Return on equity
-161.8%
This company
18.4%
Market median
-979% vs market
20122024
Net profit margin
-9590700000.0%
This company
8.1%
Market median
-118403703804% vs market
20122024
Asset turnover
-0.01×
This company
1.12×
Market median
-101% vs market
20122024
Debt / equity
0.38×
This company
0.62×
Market median
+39% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
DR Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
PB Management | Management | 2001 | — | — |
JH Management | Management | 2015 | — | — |
EB Management | Management | 2001 | — | — |
JB Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
LJ Management | Management | 2016 | — | — |
SO Management | Management | 2024 | — | — |
HA Audit | Audit | 2001 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2009 | — | — | |
| Chairman | 2001 | — | — | |
| Board of Directors | 2014 | — | — | |
| Chairman | 2025 | — | — | |
| Board of Directors | 2001 | — | — | |
| Board of Directors | 2012 | — | — | |
| Board of Directors | 2001 | — | — | |
| Board of Directors | 2014 | — | — | |
| Chairman | 2016 | — | — | |
| Board of Directors | 2007 | — | — | |
| Board of Directors | 2010 | — | — | |
| Chairman | 2014 | — | — | |
| Chairman | 2014 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2016 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
UNIBIO A/S 
Unibio CIS ApSBoard members of UNIBIO A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| David Richard Henstrom | Chief Executive Officer | 0 companies |
| Preben Bang Henriksen | Management | 0 companies |
| Jesper Halling Pedersen | Management | 0 companies |
| Ebbe Bjerne Busch Larsen | Management | 0 companies |
| Jakob Brix Christensen | Chief Executive Officer | 0 companies |
| Leif Jacobsen | Management | 0 companies |
| Søren Olrik Eklund | Management | 0 companies |
| Harry Aamann | Audit | 0 companies |
| Sten Bay Jørgensen | Board of Directors | 0 companies |
| Christen Jensen Sørensen | Chairman | 0 companies |
| Jeppe Høier | Board of Directors | 0 companies |
| Neil Goldsmith | Chairman | 0 companies |
| Johan Thomsen | Board of Directors | 0 companies |
| Keld Friis | Board of Directors | 0 companies |
| Carl Bjarne Mikkelsen | Board of Directors | 0 companies |
| Leif Kjærgaard | Board of Directors | 0 companies |
| Jan Boeg Hansen | Chairman | 0 companies |
| Henrik Busch-Larsen | Board of Directors | 0 companies |
| Mogens Hønnerup Nielsen | Board of Directors | 0 companies |
| Evert Harm Hulleman | Chairman | 0 companies |
| Jens-Erik Hinnerskov | Chairman | 0 companies |